Up-to-date List of Alopecia Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Alopecia Medical Research Studies

RankStatusStudy
1 Recruiting Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Condition: Alopecia Areata
Interventions: Device: 308-nm excimer laser to Alopecia patch;   Device: Liquid light guide tip on laser
Outcome Measures: The goal of this study is to assess the feasibility, safety and response to treatment of the use of the 308-nm excimer laser in children diagnosed with patch type Alopecia areata involving the scalp, present for more than 6 months duration;   Evaluate the feasibility and safety of twice-weekly excimer laser treatments over a period of 12 weeks
2 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
Outcome Measure: Alopecia Areata Registry
3 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Triamcinolone 2.5 mg/ml;   Drug: Triamcinolone 5 mg/ml;   Drug: Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
Outcome Measures: SALT Score;   Number of adverse events
4 Unknown  Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
Conditions: Alopecia Areata;   Alopecia;   Balding
Interventions: Procedure: Hair transplantation;   Procedure: Hypodermic needle irritation
Outcome Measure: Change in follicular growth
5 Not yet recruiting A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Abatacept;   Drug: placebo
Outcome Measures: SALT Score (Severity of Alopecia Tool);   Efficacy;   Safety
6 Recruiting An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Abatacept
Outcome Measures: SALT Score (Severity of Alopecia Tool);   Efficacy;   Safety
7 Recruiting Effect of PRP on the Therapy for Hair Growth
Condition: Hair Loss/Baldness
Intervention: Other: hair loss, baldness (patient's own platelet-rich plasma)
Outcome Measure: examination the effect of PRP on hair loss/baldness
8 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment to prevent hair loss
Outcome Measures: Efficacy;   Safety
9 Recruiting An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Ruxolitinib
Outcome Measures: Change in SALT Score;   Change in Percentage of Hair Loss;   Change in Patient Global Assessment;   Change in Physician Global Assessment (PGA) Score;   Patient Quality of Life Assessment Score;   Incidence of Adverse Effects
10 Recruiting Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
Outcome Measures: No and frontal only androgenetic Alopecia;   Vertex only and frontal and vertex androgenetic Alopecia.
11 Recruiting Excimer Light for Alopecia Areata
Condition: Alopecia Areata
Intervention: Procedure: UVB excimer light
Outcome Measures: Change in the percentage of hair regrowth for each half. We will consider the treamtment successful if there was ≥50% hair regrowth from baseline.;   Change in hair count and caliber in each half;   Assessment of side effects in each half
12 Unknown  Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
Outcome Measures: To evaluate hair regrowth with Alopecia areata subcutaneous injections of Botulinum toxin A;   Hair regrowth will be assessed after 3 months and 6 months
13 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
Outcome Measure:
14 Not yet recruiting Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Condition: Alopecia
Interventions: Drug: Dutasteride;   Drug: Placebo
Outcome Measures: Proportion of subjects with a change in sexual function defined as a negative change from baseline in the IIEF-EF score of >=4 units or a score of <=25 on or before Week 24;   Proportion of subjects with a negative change from baseline in the IIEF-EF score of >=4 units or a score of <=25 on or before Weeks 4 and 12 as well as the Follow-up Visit;   Change from baseline in total score of the IIEF at Weeks 4, 12, and 24 as well as the Follow-up Visit;   Change from baseline in the individual domain scores: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction, of the IIEF at Weeks 4, 12 and 24 as well as the Follow-up Visit;   Change from baseline in subject satisfaction with hair growth as assessed by the total score of the Hair Growth Satisfaction Scale (HGSS) at Weeks 12 and 24;   Change from baseline in the total score of the Dermatology Life Quality Index (DLQI) at Weeks 12 and 24;   Occurrence of adverse events related to sexual dysfunction
15 Unknown  Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
Outcome Measures: Improvement of pruritis, tenderness, and pain;   Absence of inflammation on biopsy
16 Recruiting The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
Outcome Measures: The percentage of terminal hair regrowth after intralesional botulinum toxin A injection;   Possible side effects of intralesional botulinum toxin a injection
17 Recruiting Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Interleukin-2
Outcome Measures: Number of patients who obtained an improvement of at least 90% of the score validated severity score in Alopecia areata in 2 months.;   Evaluation of the quality of life
18 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
Outcome Measures: hair density;   Hair diameter, anagen/telogen ratio and hair growth rate,Global photographic assessment according to Female-Ludwig scale,;   Self-administered satisfaction questionnaire
19 Unknown  Vytorin in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: vytorin
Outcome Measures: 20% Hair regrowth;   maintenance of hair
20 Unknown  Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
Outcome Measures: Severity of Alopecia Tool (SALT);   Comparison of Tamoxifen, AI or Tamoxifen plus AI

These studies may lead to new treatments and are adding insight into Alopecia etiology and treatment.

A major focus of Alopecia research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Alopecia

privacy policy